Influenza A virus hemagglutinin H5 subtype HA1 subunit head domain (H5 HA1)

The HA1 head domain of the Influenza A H5 hemagglutinin is a critical component of the viral surface glycoprotein responsible for initiating infection. It contains the receptor-binding site (RBS) that recognizes and attaches to alpha-2,3-linked sialic acids on host cell membranes, which is a hallmark of avian-adapted influenza viruses (UniProt: P03452). As the most immunodominant part of the virus, the HA1 head is the primary target for neutralizing antibodies elicited by infection or vaccination (PubMed: 28100607). However, this domain is subject to frequent antigenic drift, where mutations allow the virus to evade the host immune system, posing a significant challenge for vaccine development (NIH: PMC4776122). Therapeutic strategies targeting the H5 HA1 head include monoclonal antibodies and prepandemic vaccines designed to prevent zoonotic transmission and potential pandemic outbreaks (PubMed: 25855244). Understanding the structural biology of the HA1 head is essential for monitoring viral evolution and developing broadly neutralizing countermeasures against highly pathogenic avian influenza (HPAI) strains.

Other names

H5 HAHemagglutinin HA1 subunitH5N1 hemagglutininGlobular head domainHA1 domain

Neutralization of viral infectivity by blocking the interaction between the hemagglutinin head domain and host cell sialic acid receptors, thereby preventing viral attachment and entry (PubMed: 28100607).